Wednesday, June 29, 2011

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Wednesday, June 29, 2011 12:08 AM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Ohio House approves abortion ban after heartbeat
Tue,28 Jun 2011 04:56 PM PDT
Reuters - COLUMBUS (Reuters) - The Ohio House of Representatives on Tuesday voted to ban abortions after a fetal heartbeat is detectable, which can be as early as six weeks. Full Story1
Top

Surgeons in Medtronic trials omitted results: report
Tue,28 Jun 2011 04:26 PM PDT
Reuters - NEW YORK (Reuters) - Surgeons conducting clinical trials to test a Medtronic Inc bone-growth protein used in spine surgery, some of whom got at least $62 million from the company, failed to report serious complications in their research papers, the Wall Street Journal reported. Full Story1
Top

Aspirin might interfere with new heart drug
Tue,28 Jun 2011 02:22 PM PDT
Reuters - LONDON (Reuters) - A new study backs up a suggestion that high dosages of aspirin may interfere with AstraZeneca's heart drug Brilinta, offering a possible explanation for disappointing results from a study of patients in North America. Full Story1
Top

Kids who survive cancer more often get new tumors
Tue,28 Jun 2011 02:21 PM PDT
Reuters - NEW YORK (Reuters Health) - Children who have beaten cancer once are at increased risk of developing new tumors down the road, researchers say. Full Story1
Top

Can the Internet help you lose weight?
Tue,28 Jun 2011 02:20 PM PDT
Reuters - NEW YORK (Reuters Health) - People tend to lose a little more weight with online help than with traditional weight loss programs, according to a new study from Japan. Full Story1
Top

Patients plead to keep Avastin for breast cancer
Tue,28 Jun 2011 01:43 PM PDT
Reuters -

photoSILVER SPRING, Maryland (Reuters) - Breast cancer patients testified that Roche Holding AG's Avastin saved their lives as U.S. health officials weighed whether the world's best-selling cancer drug should remain approved for that condition.


Full Story1
Top

Death rates higher for patients in U.S. territories
Tue,28 Jun 2011 12:30 PM PDT
Reuters - NEW YORK (Reuters Health) - Hospitals in the U.S. territories see more deaths after heart attacks, heart failure and pneumonia than the states, according to a study out Tuesday. Full Story1
Top

Germany shuts school over E.coli scare
Tue,28 Jun 2011 11:47 AM PDT
Reuters - BERLIN (Reuters) - German officials closed a primary school in the west of the country on Tuesday after a number of students fell ill with the rare strain of E.coli responsible for an outbreak that has killed 48 people. Full Story1
Top

Programs may curb hepatitis C in drug users
Tue,28 Jun 2011 11:30 AM PDT
Reuters - NEW YORK (Reuters Health) - Programs that give injection drug users clean needles or safer drug substitutes may help cut their odds of contracting the liver infection hepatitis C, a new study suggests. Full Story1
Top

Malaria funding rise fills drug pipeline
Tue,28 Jun 2011 10:26 AM PDT
Reuters - LONDON (Reuters) - Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report on Tuesday. Full Story1
Top

Metformin, diet cost-effective to avert diabetes
Tue,28 Jun 2011 09:53 AM PDT
Reuters - SAN DIEGO (Reuters) - Generic drug metformin is a cost-effective way to help prevent Type 2 diabetes in people at high risk of developing the chronic condition, according to a new economic analysis. Full Story1
Top

Pediatrician group urges ban on junk food ads
Mon,27 Jun 2011 03:04 PM PDT
Reuters - LOS ANGELES/NEW YORK (Reuters) - U.S. pediatricians want to ban junk food ads aimed at children, saying that they conspire with sedentary activities like watching television and playing video games to make kids fat. Full Story1
Top

Neurontin study more marketing than science: report
Mon,27 Jun 2011 02:33 PM PDT
Reuters - NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report. Full Story1
Top

Neurontin study more marketing than science: report
Mon,27 Jun 2011 02:33 PM PDT
Reuters - NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report. Full Story1
Top

Can vitamin D lower your risk of melanoma?
Mon,27 Jun 2011 02:32 PM PDT
Reuters - NEW YORK (Reuters Health) - Taking vitamin D may help protect women who have already had non-melanoma skin cancers against a much deadlier form of the disease, suggests a new study. Full Story1
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment